+

WO2001028590A3 - COMPOSITIONS PHARMACEUTIQUES RENFERMANT UN ESTER N-[N-(3,3-DIMETHYLBUTYL)-1-α-ASPARTYL]-L-PHENYLALANINE METHYL - Google Patents

COMPOSITIONS PHARMACEUTIQUES RENFERMANT UN ESTER N-[N-(3,3-DIMETHYLBUTYL)-1-α-ASPARTYL]-L-PHENYLALANINE METHYL Download PDF

Info

Publication number
WO2001028590A3
WO2001028590A3 PCT/US2000/028731 US0028731W WO0128590A3 WO 2001028590 A3 WO2001028590 A3 WO 2001028590A3 US 0028731 W US0028731 W US 0028731W WO 0128590 A3 WO0128590 A3 WO 0128590A3
Authority
WO
WIPO (PCT)
Prior art keywords
aspartyl
dimethylbutyl
pharmaceutical compositions
methyl ester
compositions containing
Prior art date
Application number
PCT/US2000/028731
Other languages
English (en)
Other versions
WO2001028590A2 (fr
Inventor
Subbarao V Ponakala
Original Assignee
Nutrasweet Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutrasweet Co filed Critical Nutrasweet Co
Priority to AU10934/01A priority Critical patent/AU1093401A/en
Publication of WO2001028590A2 publication Critical patent/WO2001028590A2/fr
Publication of WO2001028590A3 publication Critical patent/WO2001028590A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/30—Artificial sweetening agents
    • A23L27/31—Artificial sweetening agents containing amino acids, nucleotides, peptides or derivatives
    • A23L27/32—Artificial sweetening agents containing amino acids, nucleotides, peptides or derivatives containing dipeptides or derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Preparation (AREA)
  • Seasonings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne des produits pharmaceutiques et des compositions associées renfermant du néotame. Ces compositions pharmaceutiques ont démontré avoir des caractéristiques de goût et d'arôme améliorées.
PCT/US2000/028731 1999-10-19 2000-10-18 COMPOSITIONS PHARMACEUTIQUES RENFERMANT UN ESTER N-[N-(3,3-DIMETHYLBUTYL)-1-α-ASPARTYL]-L-PHENYLALANINE METHYL WO2001028590A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU10934/01A AU1093401A (en) 1999-10-19 2000-10-18 Pharmaceutical compositions containing n-(n-(3,3-dimethylbutyl)-1-alpha-aspartyl)-l-phenylalanine methyl ester

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16030599P 1999-10-19 1999-10-19
US60/160,305 1999-10-19

Publications (2)

Publication Number Publication Date
WO2001028590A2 WO2001028590A2 (fr) 2001-04-26
WO2001028590A3 true WO2001028590A3 (fr) 2008-01-03

Family

ID=22576354

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/028731 WO2001028590A2 (fr) 1999-10-19 2000-10-18 COMPOSITIONS PHARMACEUTIQUES RENFERMANT UN ESTER N-[N-(3,3-DIMETHYLBUTYL)-1-α-ASPARTYL]-L-PHENYLALANINE METHYL

Country Status (2)

Country Link
AU (1) AU1093401A (fr)
WO (1) WO2001028590A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2859603B1 (fr) * 2003-09-11 2005-12-30 Christian Fenioux Utilisation de la neohesperidine dihydrochalcone dans des compositions orales comprenant des vitamines et/ou des mineraux
JP5852783B2 (ja) * 2011-02-25 2016-02-03 小川香料株式会社 高甘味度甘味料の呈味改善剤
GB2551987A (en) 2016-07-01 2018-01-10 Gw Res Ltd Oral cannabinoid formulations
GB2551986A (en) 2016-07-01 2018-01-10 Gw Res Ltd Parenteral formulations
GB2559774B (en) 2017-02-17 2021-09-29 Gw Res Ltd Oral cannabinoid formulations
GB2569961B (en) 2018-01-03 2021-12-22 Gw Res Ltd Pharmaceutical

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0866073A1 (fr) * 1997-03-18 1998-09-23 Ajinomoto Co., Ltd. Nouveau dérivés dipeptidiques et agents édulcorantes
WO1999012957A1 (fr) * 1997-09-11 1999-03-18 The Nutrasweet Company SELS BASIQUES DE N-[N-(3,3-DIMETHYLBUTYL)-L-α-ASPARTYL]-L-PHENYLALANINE 1-METHYL ESTER
WO1999030576A1 (fr) * 1997-12-17 1999-06-24 The Nutrasweet Company Compositions de boissons comprenant un edulcorant presentant un tres fort pouvoir sucrant
JPH11279081A (ja) * 1998-03-27 1999-10-12 Ajinomoto Co Inc 苦味物質含有組成物
WO1999057998A1 (fr) * 1998-05-08 1999-11-18 Ajinomoto Co., Inc. Compositions a base d'edulcorants
WO1999062354A1 (fr) * 1998-06-05 1999-12-09 Wm. Wrigley Jr. Company Procede pour moduler la liberation de derives n-substitues d'aspartame dans une gomme a macher et gomme ainsi produite
WO2000036933A1 (fr) * 1998-12-18 2000-06-29 The Nutrasweet Company UTILISATION D'UN ESTER METHYLIQUE DE N-NEOHEXYL-$G(a)-ASPARTYL-L-PHENYLALANINE COMME AGENT DE SAPIDITE
WO2000057726A1 (fr) * 1999-03-29 2000-10-05 The Nutrasweet Company ALIMENTS FONCTIONNELS COMPRENANT UN ESTER DE 1-METHYLE N-[N-(3,3-DIMETHYLBUTYL)-L-α-ASPARTYL]-L-PHENYLALANINE

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0866073A1 (fr) * 1997-03-18 1998-09-23 Ajinomoto Co., Ltd. Nouveau dérivés dipeptidiques et agents édulcorantes
WO1999012957A1 (fr) * 1997-09-11 1999-03-18 The Nutrasweet Company SELS BASIQUES DE N-[N-(3,3-DIMETHYLBUTYL)-L-α-ASPARTYL]-L-PHENYLALANINE 1-METHYL ESTER
WO1999030576A1 (fr) * 1997-12-17 1999-06-24 The Nutrasweet Company Compositions de boissons comprenant un edulcorant presentant un tres fort pouvoir sucrant
JPH11279081A (ja) * 1998-03-27 1999-10-12 Ajinomoto Co Inc 苦味物質含有組成物
WO1999057998A1 (fr) * 1998-05-08 1999-11-18 Ajinomoto Co., Inc. Compositions a base d'edulcorants
JPH11318381A (ja) * 1998-05-08 1999-11-24 Ajinomoto Co Inc 新規甘味料組成物
WO1999062354A1 (fr) * 1998-06-05 1999-12-09 Wm. Wrigley Jr. Company Procede pour moduler la liberation de derives n-substitues d'aspartame dans une gomme a macher et gomme ainsi produite
WO2000036933A1 (fr) * 1998-12-18 2000-06-29 The Nutrasweet Company UTILISATION D'UN ESTER METHYLIQUE DE N-NEOHEXYL-$G(a)-ASPARTYL-L-PHENYLALANINE COMME AGENT DE SAPIDITE
WO2000057726A1 (fr) * 1999-03-29 2000-10-05 The Nutrasweet Company ALIMENTS FONCTIONNELS COMPRENANT UN ESTER DE 1-METHYLE N-[N-(3,3-DIMETHYLBUTYL)-L-α-ASPARTYL]-L-PHENYLALANINE

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 200006, Derwent World Patents Index; AN 2000-053011 *
PATENT ABSTRACTS OF JAPAN vol. 2000, no. 1 31 January 2000 (2000-01-31) *

Also Published As

Publication number Publication date
AU1093401A (en) 2001-04-30
WO2001028590A2 (fr) 2001-04-26

Similar Documents

Publication Publication Date Title
EP0875252A3 (fr) Formulations de protéine C activée
AU3680300A (en) Sucralose-containing composition and eatable product comprising the same
AU5397699A (en) Pasteurized or ultra-pasteurized complete nutritional compositions and products
IL150539A0 (en) Novel 1,3-dihydro-2h-indol-2-one derivatives, preparation method and pharmaceutical compositions containing them
HUP0004400A3 (en) Dipeptide nitriles, process for their preparation, pharmaceutical compositions comprising thereof and their use
EP1529776A3 (fr) Dérivés d'aminoacides et agent édulcorant
AU7363600A (en) Breath freshening comestible product
HUP0004310A3 (en) Cyclic amino acids, and derivatives thereof and pharmaceutical compositions comprising the said compounds as active agents
HUP0204519A3 (en) 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity, pharmaceutical compositions containing them and process for their preparations
IL159086A0 (en) 3-aryl-5-aryl- [1, 2, 4] -oxadiazole derivatives and pharmaceutical compositions containing the same
AU2001267741A1 (en) Flavour product
AU2417100A (en) N-(n-(3,3-dimethylbutyl)-l-alpha-aspartyl)-l-phenylalanine 1-methyl ester synergistic sweetener blends
AP2004003154A0 (en) Novel perindopril salt and pharmaceutical compositions containing same.
AU2001235737A1 (en) Novel 1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same
WO1998019697A3 (fr) Compositions pharmaceutiques nouvelles
HUP0003734A2 (en) Salts of n-[n-(3,3-dimethylbutyl)-l-alpha-aspartyl]-l-phenylalanine 1-methyl ester, sweetener compositions containing them
BR0005332A (pt) Aroma encapsulado
WO2001028590A3 (fr) COMPOSITIONS PHARMACEUTIQUES RENFERMANT UN ESTER N-[N-(3,3-DIMETHYLBUTYL)-1-α-ASPARTYL]-L-PHENYLALANINE METHYL
HK1029928A1 (en) Pharmaceutical compositions of peptides having lowsolubility in physiological medium.
HUP0003574A3 (en) Metal complexes of n-[n-(3,3-dimethylbutyl)-l-alpha-aspartyl]-l-phenylalanine 1-methyl ester
FR2778066B1 (fr) Composition edulcorante et produits alimentaires la contenant
AU6238800A (en) Confectionery food products sweetened with n-[n-(3,3-dimethylbutyl)-1-alpha-aspartyl]-l-phenylalanine methyl ester
AU2683700A (en) Flavour/aroma materials and their preparation
AU1094301A (en) Personal care products using n-(n-(3,3-dimethylbutyl)-1-alpha-aspartyl)-l-phenylalanine methyl ester
AU4644299A (en) Synthetic peptides and pharmaceutical compositions comprising them for diagnosisand treatment of anti-phospholipid syndrome

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
NENP Non-entry into the national phase

Ref country code: DE

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载